Stocks
Impax Laboratories, Inc.IPXL
NASDAQHealthcarePharmaceuticals$18.30+0.55%
A specialty pharmaceutical manufacturer focused on developing, producing, and marketing generic and branded medications, with particular strength in complex generics and central nervous system therapies. The company operated both a generic drug portfolio and a smaller branded segment targeting neuro...
Market Cap: $052W Range: $13.00 – $25.70
Congressional Interest in Impax Laboratories, Inc. (IPXL)
2 members of Congress have disclosed 4 trades in Impax Laboratories, Inc. (IPXL), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
2
Buys
3
Sells
1
Who in Congress Is Trading IPXL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-31 | Josh Gottheimer | buy | $1K – $15K |
| 2012-03-10 | MICHAEL T. MCCAUL | sell | $15K – $50K |